AstraZeneca reports 6% rise in Q2 2024 net profit to $1.92bn
The British pharmaceutical company reported total revenues of $12.93bn for Q2 2024, a 13% increase compared to $11.41bn for the same quarter in 2023, and a 2% rise compared to $12.67bn for Q1 2024